ArticleThe Eurasian journal of medicine2023
Artificial Intelligence in Stroke Imaging: A Comprehensive Review.
Article in The Eurasian journal of medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Artificial Intelligence in Ischemic Stroke Lesion Segmentation: A Narrative Review of Deep Learning Methods, Clinical Utility, and Future Directions.Journal of imaging informatics in medicine · 2026Review
- The Role of AI-Based Software BrainScan in the Interpretation of Non-Contrast Head CT in Acute Ischemic Stroke: An External Validation Study.Neurology international · 2026Article
- Current State of the Clinical Applications of Artificial Intelligence in Stroke: A Literature Review.Brain sciences · 2026Review
- Intersections and Challenges in the Management of Acute Coronary Syndrome and Stroke: Pathophysiology, Treatment Dilemmas, and Integrated Prevention Strategies.Journal of clinical medicine · 2025Review
- Artificial Intelligence and Neuroscience: Transformative Synergies in Brain Research and Clinical Applications.Journal of clinical medicine · 2025Review
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The aging population challenges the health-care system with chronic diseases. Cerebrovascular diseases are important components of these chronic conditions. Stroke is the acute cessation of blood in the brain, which can lead to rapid tissue loss. Therefore, fast, accurate, and reliable automatic methods are required to facilitate stroke management. The performance of artificial intelligence (AI) methods is increasing in all domains. Vision tasks, including natural images and medical images, are particularly benefiting from the skills of AI models. The AI methods that can be applied to stroke imaging have a broad range, including classical machine learning tools such as support vector machines, random forests, logistic regression, and linear discriminant analysis, as well as deep learning models, such as convolutional neural networks, recurrent neural networks, autoencoders, and U-Net. Both tools can be applied to various aspects of stroke management, including time-to-event onset determination, stroke confirmation, large vessel occlusion detection, difusion restriction, perfusion deficit, core and penumbra identification, afected region segmentation, and functional outcome prediction. While building these AI models, maximum care should be exercised in order to reduce bias and build generalizable models. One of the most important prerequisites for building unbiased models is collecting large, diverse, and quality data that reflects the underlying population well and splitting the training and testing parts in a way that both represent a similar distribution. Explainability and trustworthiness are other important properties of machine learning models that could be widely adopted in clinical practices.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.